Company profile
Diagnodus Ltd
DiagNodus: Colorectal Diagnostic Technologies
A biotechnology company developing novel diagnostic tools in the area of colorectal disease
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Detection of SARS-CoV-2 RNA presence in colorectal mucus collected from patients recovering from COVID-19 for assessing the risk of exposure to the virus in medical professionals performing invasive colorectal procedures including endoscopy.
1 Jul 2020 to 31 Mar 2021
The COVID-19 pandemic not only affects millions of people, but also generates high levels of risk for medical professionals caring for their patients. It is established that the virus induces predominantly respiratory symptoms that are often culminated by the development of severe pneumonias, and COVID-19 mostly spreads through aerosol droplets generated ...
Colorectal cancer detection by quantifying biomarkers in non-invasively collected colorectal mucus.
1 Feb 2017 to 31 Jan 2018
Colorectal cancer (CRC) is a severe disease causing about 10% of all cancer deaths in the UK. Many CRC cases are diagnosed too late to be successfully treated, and early detection of CRC remains an urgent healthcare problem. This project aims to evaluate the feasibility of our recently invented technique of non-invasive sample collection and analysis as a...
Development of new non-invasive tests for inflammatory bowel disease detection, monitoring and treatment assessment.
1 Sep 2013 to 28 Feb 2015
Inflammatory bowel disease (IBD) is a group of common chronic diseases involving bowel inflammation. Ulcerative colitis and Crohn’s disease are the most important conditions of this group. IBD is usually diagnosed in young adults. As a rule it is characterized by long remissions and incidental flare-ups requiring treatment. IBD should be distinguished fro...